S4374 | Requires practitioners who administer naloxone or another overdose reversal agent to a patient to report the administration of the agent to the prescription monitoring program registry | Smith & Moses
Requires practitioners who administer naloxone or another overdose reversal agent to a patient to report the administration of the agent to the prescription monitoring program registry
2017-2018 SessionGeorge AmedoreAffects: Public Health Law